Search for: "Watson Laboratories Inc" Results 101 - 120 of 143
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Apr 2012, 9:05 am by FDABlog HPM
The owners of the three approved ANDAs for generic oral vancomycin—Akorn, Incorporated (“Akorn”), Watson Laboratories, Inc. [read post]
1 Dec 2011, 2:02 pm by Tom Lamb
(NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Vestura(TM) (3 mg drospirenone and 0.02 mg ethinyl estradiol), a generic version of Bayer's Yaz(R) oral contraceptive product. [read post]
9 Nov 2007, 4:44 am
See, e.g., the Board's 2004 decision in favor of registrability of MOSCONI for billiard equipment (TTABlogged here), and this year's refusal of WATSON for laboratory software (here).Text Copyright John L. [read post]
26 Feb 2014, 5:37 pm
  Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
1 Apr 2013, 8:29 am by Gene Quinn
” Upon receiving this reissue patent, Pfizer immediately filed a lawsuit against Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
23 Jan 2010, 9:40 am by Bill Marler
The Salmonella strain in the tested product does not appear to be the Montevideo strain of interest and further testing of the sample is ongoing at a state health partner laboratory. [read post]
23 Jan 2010, 9:46 am by Bill Marler
The Salmonella strain in the tested product does not appear to be the Montevideo strain of interest and further testing of the sample is ongoing at a state health partner laboratory. [read post]
11 Feb 2013, 6:44 pm by FDABlog HPM
District Court for the District of Columbia ruled against FDA in a challenge brought by Watson Laboratories, Inc. [read post]
23 Sep 2010, 12:39 pm by FDABlog HPM
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc.’s ANDA No. 78-278 for a generic version of the herpes drug FAMVIR (famciclovir) Tablets.  [read post]
16 Oct 2006, 7:58 pm
Solvay Pharmaceuticals settled patent litigation with generic drug makers Par Pharmaceutical Cos. and Watson Pharmaceuticals Inc. over Solvay's AndroGel drug product. [read post]
27 Sep 2010, 12:59 am by FDABlog HPM
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc.’s ANDA No. 78-278 for a generic version of the herpes drug FAMVIR (famciclovir) Tablets, FDA, on September 24th, updated the Agency’s drug approval database (Drugs@FDA) to show that ANDA No. 78-278 is tentatively approved.  [read post]
10 Jul 2013, 12:00 am
Watson Pharm., Inc. that routine experimentation is "not without bounds. [read post]